Purification of multiple heat shock proteins from a single tumor sample

被引:29
作者
Ménoret, A [1 ]
Bell, G [1 ]
机构
[1] Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT 06030 USA
关键词
heat shock protein; immunity; heparin; chromatography; cancer;
D O I
10.1016/S0022-1759(00)00137-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Heat shock protein-based vaccines have been shown to immunize against cancer and infectious diseases in both prophylactic and therapeutic protocols. So far, four classes of heat shock proteins (HSPs) preparation: gp96, HSP90 (hsp86, hsp84), HSP70 (hsc70, hsp70) and calreticulin have been used successfully. The methods for purifying them individually are now readily available. However, since tumors are not always available in large quantity, a major challenge remains the development of a procedure to simultaneously isolate these HSPs from the same sample. We report here that hsp40, hsp60, hsc70, hsp70, hsp84, hsp86, and gp96 (grp94) but not BiP (grp78) and calreticulin can be separated from a single tumor sample in one step using heparin-agarose chromatography. Interestingly this procedure separates the HSP70 isoforms hsp70 from hsc70, but not the HSP90 isoforms hsp84 and hsp86. The three main immunogenic HSPs, gp96, hsp86/84, and hsc70 can be further isolated to homogeneity using additional purification methods. In addition, we have shown that the interaction of the chaperoned peptides with hsc70 and gp96 is not compromised during heparin chromatography. These observations provide a new method for preparation of multiple HSP-based vaccines, circumventing the sample size limitation, as well as providing the possibility to study how multiple HSPs can synergize in eliciting immunity. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:119 / 130
页数:12
相关论文
共 33 条
[1]  
AMATO R, 1999, ASCO M
[2]   CROSS-PRIMING OF MINOR HISTOCOMPATIBILITY ANTIGEN-SPECIFIC CYTOTOXIC T-CELLS UPON IMMUNIZATION WITH THE HEAT-SHOCK PROTEIN GP96 [J].
ARNOLD, D ;
FAATH, S ;
RAMMENSEE, HG ;
SCHILD, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :885-889
[3]   Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity [J].
Basu, S ;
Srivastava, PK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :797-802
[4]  
Berd D, 1998, SEMIN ONCOL, V25, P646
[5]   Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity [J].
Blachere, NE ;
Li, ZH ;
Chandawarkar, RY ;
Suto, R ;
Jaikaria, NS ;
Basu, S ;
Udono, H ;
Srivastava, PK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) :1315-1322
[6]  
Breloer M, 1998, EUR J IMMUNOL, V28, P1016, DOI 10.1002/(SICI)1521-4141(199803)28:03<1016::AID-IMMU1016>3.0.CO
[7]  
2-G
[8]  
CIUPTU AM, 1988, J EXP MED, V5, P685